Leandro M. Colli

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses

Leandro M. Colli, Mitchell J. Machiela, Timothy A. Myers et al. · Cancer Research · 2016 · 140 citations · Full text

Nonsynonymous Mutations, Checkpoint Inhibitor Treatment, Immunology +16

Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma

Jiyeon Choi, Tongwu Zhang, Andrew Vu et al. · Nature Communications · 2020 · 139 citations · Full text

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Abdul Rouf Banday, Megan L. Stanifer, Oscar Flórez-Vargas et al. · Nature Genetics · 2022 · 132 citations · Full text

Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management

Leandro M. Colli, Mitchell J. Machiela, Han Zhang et al. · Cancer Research · 2017 · 126 citations